Gluskin Sheff (TSE:GS)’s share price reached a new 52-week high during trading on Wednesday after Scotiabank raised their price target on the stock from C$18.00 to C$19.00. Scotiabank currently has a sector perform rating on the stock. Gluskin Sheff traded as high as C$16.46 and last traded at C$16.50, with a volume of 361566 shares. The stock had previously closed at C$16.30.
A number of other equities analysts have also commented on the company. Desjardins reaffirmed a “hold” rating on shares of Gluskin Sheff in a research note on Monday. BMO Capital Markets lifted their price objective on Gluskin Sheff from C$16.00 to C$17.00 in a research note on Tuesday. Finally, CIBC cut their price objective on Gluskin Sheff from C$17.50 to C$17.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 17th. Six research analysts have rated the stock with a hold rating, The company has an average rating of “Hold” and an average target price of C$17.58.
In other Gluskin Sheff news, insider Jeffrey Moody purchased 15,000 shares of the company’s stock in a transaction on Thursday, March 8th. The shares were purchased at an average cost of C$14.22 per share, with a total value of C$213,300.00. Also, insider Jim Demetris Bantis purchased 10,000 shares of the company’s stock in a transaction on Monday, March 12th. The stock was acquired at an average cost of C$14.40 per share, for a total transaction of C$144,000.00. Over the last three months, insiders acquired 51,000 shares of company stock worth $733,810.
About Gluskin Sheff
Gluskin Sheff + Associates Inc is a publicly owned investment manager. The firm also provides wealth management services. It primarily provides its services to high net worth investors, including entrepreneurs, professionals, family trusts, private charitable foundations, pension and profit sharing plans, pooled investment vehicles, charitable organizations , corporations, institutions, insurance companies, and estates.
Receive News & Ratings for Gluskin Sheff Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gluskin Sheff and related companies with MarketBeat.com's FREE daily email newsletter.